Tweet
WASHINGTON (AP) -- The Food and Drug Administration said Thursday it is investigating a possible link between Merck's best-selling Singulair and suicide.
FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy and asthma drug.
Merck has updated the drug's labeling four times in the past year to include information on a range of reported side effects: tremors, anxiousness, depression and suicidal behavior.
Full Story: http://www.nytimes.com/aponline/busi...tml?ref=health
FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy and asthma drug.
Merck has updated the drug's labeling four times in the past year to include information on a range of reported side effects: tremors, anxiousness, depression and suicidal behavior.
Full Story: http://www.nytimes.com/aponline/busi...tml?ref=health